[Propanc Biopharma Plans to Acquire Digital Asset Management Company with Market Value Below Net Asset Value] Propanc Biopharma (NASDAQ: PPCB) announced its intention to acquire a Digital Asset Management (DAT) company with a market value below net asset value (MNAV) to optimize its balance sheet, diversify assets, and enhance long-term shareholder value. Such companies typically hold significant amounts of mainstream digital assets like Bitcoin and Ethereum. The Propanc board and management team are currently evaluating potential acquisition targets and developing a due diligence framework to comprehensively review the target company's balance sheet, digital asset holdings, and operational synergies.